Julio Badié

5.8k total citations · 1 hit paper
25 papers, 1.2k citations indexed

About

Julio Badié is a scholar working on Epidemiology, Surgery and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Julio Badié has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 11 papers in Surgery and 6 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Julio Badié's work include Sepsis Diagnosis and Treatment (12 papers), Hemodynamic Monitoring and Therapy (11 papers) and Intensive Care Unit Cognitive Disorders (5 papers). Julio Badié is often cited by papers focused on Sepsis Diagnosis and Treatment (12 papers), Hemodynamic Monitoring and Therapy (11 papers) and Intensive Care Unit Cognitive Disorders (5 papers). Julio Badié collaborates with scholars based in France, Argentina and United States. Julio Badié's co-authors include Marc Feissel, J Faller, Paolo Merlani, Karim Bendjelid, Jean‐Pierre Quenot, Jean–Louis Teboul, Chaouki Mezher, Guillaume Louis, Florent Montini and Vincent Gendrin and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Critical Care Medicine.

In The Last Decade

Julio Badié

25 papers receiving 1.1k citations

Hit Papers

Liberal or Conservative O... 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julio Badié France 15 381 381 304 300 266 25 1.2k
Jihad Mallat France 22 552 1.4× 577 1.5× 448 1.5× 302 1.0× 204 0.8× 96 1.5k
Amélie Seguin France 16 197 0.5× 251 0.7× 434 1.4× 281 0.9× 128 0.5× 36 1.2k
Guillaume Louis France 18 403 1.1× 307 0.8× 371 1.2× 207 0.7× 113 0.4× 44 1.2k
Francesco Gavelli Italy 19 349 0.9× 278 0.7× 295 1.0× 135 0.5× 124 0.5× 62 953
Naïke Bigé France 21 308 0.8× 458 1.2× 190 0.6× 168 0.6× 122 0.5× 67 1.1k
Pierre Perez France 15 310 0.8× 708 1.9× 338 1.1× 289 1.0× 107 0.4× 32 1.5k
Giuseppe Natalini Italy 18 387 1.0× 116 0.3× 484 1.6× 131 0.4× 353 1.3× 53 1.2k
Jonathan A. Silversides United Kingdom 14 339 0.9× 386 1.0× 420 1.4× 339 1.1× 76 0.3× 25 1.2k
Melinda Carter United States 12 260 0.7× 596 1.6× 163 0.5× 314 1.0× 109 0.4× 16 1.4k
Daniel E. Leisman United States 14 207 0.5× 433 1.1× 170 0.6× 202 0.7× 416 1.6× 31 1.1k

Countries citing papers authored by Julio Badié

Since Specialization
Citations

This map shows the geographic impact of Julio Badié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julio Badié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julio Badié more than expected).

Fields of papers citing papers by Julio Badié

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julio Badié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julio Badié. The network helps show where Julio Badié may publish in the future.

Co-authorship network of co-authors of Julio Badié

This figure shows the co-authorship network connecting the top 25 collaborators of Julio Badié. A scholar is included among the top collaborators of Julio Badié based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julio Badié. Julio Badié is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dargent, Auguste, Abderrahmane Bourredjem, Marine Jacquier, et al.. (2025). Dexmedetomidine to Reduce Vasopressor Resistance in Refractory Septic Shock: α2 Agonist Dexmedetomidine for REfractory Septic Shock (ADRESS): A Double-Blind Randomized Controlled Pilot Trial. Critical Care Medicine. 53(4). e884–e896. 3 indexed citations
2.
Bollaert, Pierre‐Édouard, Alexandra Monnier, Francis Schneider, et al.. (2023). Fluid balance control in critically ill patients: results from POINCARE-2 stepped wedge cluster-randomized trial. Critical Care. 27(1). 14 indexed citations
3.
Dargent, Auguste, Abderrahmane Bourredjem, Laurent Argaud, et al.. (2022). Dexmedetomidine to reduce vasopressor resistance in refractory septic shock: Protocol for a double-blind randomized controlled pilot trial (ADRESS Pilot study). Frontiers in Medicine. 9. 968274–968274. 3 indexed citations
4.
Gaudry, Stéphane, Saber Davide Barbar, Laurent Martin‐Lefèvre, et al.. (2022). Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studies. Critical Care. 26(1). 93–93. 37 indexed citations
5.
Klopfenstein, Timothée, Vincent Gendrin, Thierry Conrozier, et al.. (2021). Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab’s Place in COVID-19 Pneumonia. Infectious Diseases and Therapy. 10(3). 1195–1213. 14 indexed citations
6.
Klopfenstein, Timothée, Souheil Zayet, Anne Lohse, et al.. (2020). Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients. Médecine et Maladies Infectieuses. 50(5). 397–400. 178 indexed citations
7.
Lohse, Anne, Timothée Klopfenstein, Pierre‐Yves Royer, et al.. (2020). Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19). Microbes and Infection. 22(9). 500–503. 14 indexed citations
8.
Conrozier, Thierry, Anne Lohse, Jean‐Charles Balblanc, et al.. (2020). Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaboration.. PubMed. 38(4). 742–747. 32 indexed citations
9.
Agrinier, Nelly, Alexandra Monnier, Laurent Argaud, et al.. (2019). Effect of fluid balance control in critically ill patients: Design of the stepped wedge trial POINCARE-2. Contemporary Clinical Trials. 83. 109–116. 4 indexed citations
10.
Quenot, Jean‐Pierre, Julie Helms, Abderrahmane Bourredjem, et al.. (2019). Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trial. Annals of Intensive Care. 9(1). 75–75. 20 indexed citations
11.
Philippe, Laure, et al.. (2015). Fatal Thrombotic Thrombocytopenic Purpura in a Psoriasis Patient Treated with Ustekinumab and Methotrexate. Acta Dermato Venereologica. 95(4). 495–496. 4 indexed citations
12.
Feissel, Marc, Serge Aho, Romain Tapponnier, et al.. (2015). Pulse Wave Transit Time Measurements of Cardiac Output in Septic Shock Patients: A Comparison of the Estimated Continuous Cardiac Output System with Transthoracic Echocardiography. PLoS ONE. 10(6). e0130489–e0130489. 11 indexed citations
14.
Pavon, Arnaud, Christine Binquet, Fady Kara, et al.. (2013). Profile of the Risk of Death After Septic Shock in the Present Era. Critical Care Medicine. 41(11). 2600–2609. 67 indexed citations
15.
Feissel, Marc, et al.. (2009). Clinical Relevance of Echocardiography in Acute Severe Dyspnea. Journal of the American Society of Echocardiography. 22(10). 1159–1164. 11 indexed citations
16.
Feissel, Marc, et al.. (2009). Plethysmography variability index: a new fluid responsiveness parameter. Critical Care. 13(Suppl 1). P205–P205. 4 indexed citations
17.
Feissel, Marc, Jean–Louis Teboul, Paolo Merlani, et al.. (2007). Plethysmographic dynamic indices predict fluid responsiveness in septic ventilated patients. Intensive Care Medicine. 33(6). 993–999. 176 indexed citations
18.
Dubín, Arnaldo, Gastón Murias, Bernardo Maskin, et al.. (2005). Increased blood flow prevents intramucosal acidosis in sheep endotoxemia: a controlled study. Critical Care. 9(2). R66–73. 17 indexed citations
19.
Dubín, Arnaldo, Elisa Estenssoro, Gastón Murias, et al.. (2001). Effects of hemorrhage on gastrointestinal oxygenation. Intensive Care Medicine. 27(12). 1931–1936. 37 indexed citations
20.
Dubín, Arnaldo, Gastón Murias, Elisa Estenssoro, et al.. (2000). End-tidal CO2 pressure determinants during hemorrhagic shock. Intensive Care Medicine. 26(11). 1619–1623. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026